Mologic
Bedford Technology Park
Thurleigh
Bedford
MK44 2YP
United Kingdom
Tel: 44-0-1234-780020
Website: https://mologic.co.uk
Email: info@mologic.co.uk
About Mologic
Mologic Ltd, which develops powerful, personalised diagnostics to improve the lives of patients.YEAR FOUNDED:
2003
LEADERSHIP:
Founders: Paul Davis and Mark Davis
Founder and CEO: Mark Davis
FOLLOW MOLOGIC:
Tweets by Mologic
20 articles with Mologic
-
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
-
Biopharma companies from around the globe provide updates on their businesses and pipelines.
-
Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.
-
Avacta and Mologic Announce Commercial Partnership
2/8/2021
Partnership to accelerate CE marking of Avacta’s SARS-CoV-2 rapid antigen test and support COVID-19 testing in low and middle income countries
-
BioSpace Global Roundup, May 14
5/14/2020
Biopharma and life sciences companies from across the globe provide updates on their pipeline and business. -
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 11, 2020.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 20, 2020.
-
Mologic awarded c.£1 million by UK government to develop rapid diagnostic test for COVID-19
3/6/2020
Grant awarded by the Wellcome Trust and DFID, as part of UK government’s £46 million international COVID-19 prevention and research package
-
BioSpace Global Roundup, Feb. 27
2/27/2020
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations. -
Mologic launches clinical trial for validation of point-of-care COPD exacerbation alert system
11/20/2019
Observational, multi-centre validation trial carried out in collaboration with a consortium of leading clinicians and clinical centres
-
Sherlock Biosciences and Mologic Establish Strategic Partnership to Develop Instrument-free Molecular Diagnostic Tests
10/30/2019
Collaboration facilitated by the Bill & Melinda Gates Foundation through an expansion of an existing grant to Mologic
-
Mologic and University College London Hospitals collaborating in major clinical trial for early detection of sepsis
9/13/2019
Mologic Ltd announced that it has finished recruitment to a major clinical trial with University College London Hospitals (UCLH) to evaluate the Company’s point-of-care (POC) diagnostic test for the early detection of sepsis.
-
Companies from across the globe provide updates to their pipelines and businesses, with news from BioNTech, Mologic, Akcea, RedHill, and more.
-
Mologic achieves breakthrough in ultra-sensitive point-of-care diagnostics and develops new platform technology
5/7/2019
Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, services and products, today announced it has completed the development of a next generation ultra-sensitive lateral flow-based technology platform. Initially being exemplified through the development of low cost, high performance devices for malaria and HIV, the novel diagnostics can be visually read and demonstrate up to a 1,000-fold improvement in sensitivity over current technology.
-
BioSpace Movers and Shakers: April 5
4/5/2019
Pharma, biotech and life science companies strengthen leadership teams, with news from Vertex, Arvinas, Provention, Enterome, and more. -
Mologic expands US and UK operations
4/1/2019
Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, services and products, today announced it has completed the latest phase of the Company’s expansion plans.
-
Mologic Commences Clinical Trial of Urine-Based Diagnostic for Cystic Fibrosis
8/2/2018
Mologic Ltd, a developer of powerful, personalised diagnostics to improve the lives of patients, today announced that it has commenced a clinical trial to evaluate the Company’s urine-based diagnostic, HeadsUp, in monitoring pulmonary exacerbation in cystic fibrosis (CF) patients.
-
Mologic Signs Agreements with Medisur and Peripal to Distribute PERiPLEX POC Diagnostic in Europe
5/2/2018
Mologic Ltd announced that it has signed agreements with medical technology companies, Medisur and Peripal AG to distribute PERiPLEX®.
-
Mologic Strengthens Team With the Appointment of Mitch Brooker As General Manager
10/30/2017
Mitch will use his skills and experience to help lead these changes and take products from conception through to manufacture and commercialisation.
-
Mologic Receives CE Mark Approval For Bvpro Point-Of-Care Diagnostic For Patients With Bacterial Vaginosis
9/18/2017